AmacaThera

About:

AmacaThera's injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes.

Twitter/X: AmacaThera

Top Investors: Creative Destruction Lab (CDL), Lumira Ventures, Inveready, MaRS Investment Accelerator Fund, MBX Capital

Description:

AmacaThera is a clinical-stage biotechnology company developing a novel drug delivery platform to improve patient outcomes across multiple therapeutic areas, including post‑surgical pain management, cancer, and other hard‑to‑reach target areas. AmacaThera is developing combination products at the interface of biomaterials and pharmaceuticals.

Total Funding Amount:

$16M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2016-04-26

Contact Email:

info(AT)amacathera.ca

Founders:

Mike Cooke, Molly Shoichet

Number of Employees:

1-10

Last Funding Date:

2023-12-01

IPO Status:

Private

Industries: